Familial Hypercholesterolemia and Lipoprotein Apheresis

Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Hisashi, Koezuka, Ryo, Tamanaha, Tamiko, Ogura, Masatsune, Matsuki, Kota, Hosoda, Kiminori, Harada-Shiba, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711846/
https://www.ncbi.nlm.nih.gov/pubmed/31231083
http://dx.doi.org/10.5551/jat.RV17033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711846/
https://www.ncbi.nlm.nih.gov/pubmed/31231083
http://dx.doi.org/10.5551/jat.RV17033

Ejemplares similares